Ai In Drug Discovery And Future Prospects

Abstract

The Goal Of The Computer Science Subfield Of Artificial Intelligence Is To Create Systems That Are Capable Of Doing Tasks That Are Typically Performed By Humans. Artificial Intelligence Has Been Incorporated Into The Pharmaceutical And Management. Because AI Can Analyse Massive Datasets And Predict Drug-target (receptor) Interactions, It Can Significantly Reduce Time And Expenditure In The Drug Discovery Process.Artificial Intelligence (AI) Algorithms That Evaluate Actual Patient Data Can Support Personalized Medical Strategies, Improving Patient Adherence And Treatment Results. This Thorough Analysis Looks At Drug Discovery And Potential Future Developments. The Pharmaceutical Business Is Currently Experiencing A Boom Period In Artificial Intelligence, Which Is Creating Opportunities For The Discovery Of Numerous Novel Drugs. Human Disease Rates Are Rising Dramatically, Yet The Number Of Drugs Available To Treat Or Cure These Conditions Is Very Small. However, This Type Of Situation Won't Exist In The Future Due To The Pharmaceutical Industry's Integration With AI, Which Speeds Up Medication Discovery And Improves Clinical Outcomes. AI-based Drug Discovery Techniques Are Being Used By Numerous Pharmaceutical Companies To Treat A Variety Of Illnesses, Including Parkinson's Disease, Diabetes, Alzheimer's, Obsessive Compulsive Disorder, Etc.

Keywords